Report Cover

Global Irbesartan Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Combination Drugs
    Prescribed Drugs

Segment by Application
    Hyperlipidemia
    High Blood Pressure
    Heart Failure
    Kidney Disease
    Fibrous Fibrillation
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Teva
    Sanofi
    BMS
    Sumitomo Dainippon Pharma
    Novartis
    Shionogi
    Hanall
    Taj Pharmaceuticals
    Apotex
    Jiangsu Hengrui Medicine
    Verdant Life Sciences
    Angita Pharma
    Auro Pharma
    Avanstra
    Zhuhai Rundu Pharma
    Xiansheng Pharmaceutical
    CTTQ
    Tianjin Huairen Pharmaceutical
    Jiangsu Wangao Pharmaceutical
    Zhejiang Huahai Pharmaceutical
    Zhejiang Ainuo Pharmaceutical
    Yuanhe Pharmaceutical
1 Irbesartan Market Overview
    1.1 Product Overview and Scope of Irbesartan
    1.2 Irbesartan Segment by Type
        1.2.1 Global Irbesartan Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Combination Drugs
        1.2.3 Prescribed Drugs
    1.3 Irbesartan Segment by Application
        1.3.1 Irbesartan Sales Comparison by Application: (2021-2027)
        1.3.2 Hyperlipidemia
        1.3.3 High Blood Pressure
        1.3.4 Heart Failure
        1.3.5 Kidney Disease
        1.3.6 Fibrous Fibrillation
        1.3.7 Other
    1.4 Global Irbesartan Market Size Estimates and Forecasts
        1.4.1 Global Irbesartan Revenue 2016-2027
        1.4.2 Global Irbesartan Sales 2016-2027
        1.4.3 Irbesartan Market Size by Region: 2016 Versus 2021 Versus 2027

2 Irbesartan Market Competition by Manufacturers
    2.1 Global Irbesartan Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Irbesartan Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Irbesartan Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Irbesartan Manufacturing Sites, Area Served, Product Type
    2.5 Irbesartan Market Competitive Situation and Trends
        2.5.1 Irbesartan Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Irbesartan Players Market Share by Revenue
        2.5.3 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Irbesartan Retrospective Market Scenario by Region
    3.1 Global Irbesartan Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Irbesartan Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Irbesartan Market Facts & Figures by Country
        3.3.1 North America Irbesartan Sales by Country
        3.3.2 North America Irbesartan Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Irbesartan Market Facts & Figures by Country
        3.4.1 Europe Irbesartan Sales by Country
        3.4.2 Europe Irbesartan Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Irbesartan Market Facts & Figures by Region
        3.5.1 Asia Pacific Irbesartan Sales by Region
        3.5.2 Asia Pacific Irbesartan Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Irbesartan Market Facts & Figures by Country
        3.6.1 Latin America Irbesartan Sales by Country
        3.6.2 Latin America Irbesartan Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Irbesartan Market Facts & Figures by Country
        3.7.1 Middle East and Africa Irbesartan Sales by Country
        3.7.2 Middle East and Africa Irbesartan Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Irbesartan Historic Market Analysis by Type
    4.1 Global Irbesartan Sales Market Share by Type (2016-2021)
    4.2 Global Irbesartan Revenue Market Share by Type (2016-2021)
    4.3 Global Irbesartan Price by Type (2016-2021)

5 Global Irbesartan Historic Market Analysis by Application
    5.1 Global Irbesartan Sales Market Share by Application (2016-2021)
    5.2 Global Irbesartan Revenue Market Share by Application (2016-2021)
    5.3 Global Irbesartan Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Teva
        6.1.1 Teva Corporation Information
        6.1.2 Teva Description and Business Overview
        6.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Teva Product Portfolio
        6.1.5 Teva Recent Developments/Updates
    6.2 Sanofi
        6.2.1 Sanofi Corporation Information
        6.2.2 Sanofi Description and Business Overview
        6.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Sanofi Product Portfolio
        6.2.5 Sanofi Recent Developments/Updates
    6.3 BMS
        6.3.1 BMS Corporation Information
        6.3.2 BMS Description and Business Overview
        6.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 BMS Product Portfolio
        6.3.5 BMS Recent Developments/Updates
    6.4 Sumitomo Dainippon Pharma
        6.4.1 Sumitomo Dainippon Pharma Corporation Information
        6.4.2 Sumitomo Dainippon Pharma Description and Business Overview
        6.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Sumitomo Dainippon Pharma Product Portfolio
        6.4.5 Sumitomo Dainippon Pharma Recent Developments/Updates
    6.5 Novartis
        6.5.1 Novartis Corporation Information
        6.5.2 Novartis Description and Business Overview
        6.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Novartis Product Portfolio
        6.5.5 Novartis Recent Developments/Updates
    6.6 Shionogi
        6.6.1 Shionogi Corporation Information
        6.6.2 Shionogi Description and Business Overview
        6.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Shionogi Product Portfolio
        6.6.5 Shionogi Recent Developments/Updates
    6.7 Hanall
        6.6.1 Hanall Corporation Information
        6.6.2 Hanall Description and Business Overview
        6.6.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Hanall Product Portfolio
        6.7.5 Hanall Recent Developments/Updates
    6.8 Taj Pharmaceuticals
        6.8.1 Taj Pharmaceuticals Corporation Information
        6.8.2 Taj Pharmaceuticals Description and Business Overview
        6.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Taj Pharmaceuticals Product Portfolio
        6.8.5 Taj Pharmaceuticals Recent Developments/Updates
    6.9 Apotex
        6.9.1 Apotex Corporation Information
        6.9.2 Apotex Description and Business Overview
        6.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Apotex Product Portfolio
        6.9.5 Apotex Recent Developments/Updates
    6.10 Jiangsu Hengrui Medicine
        6.10.1 Jiangsu Hengrui Medicine Corporation Information
        6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
        6.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Jiangsu Hengrui Medicine Product Portfolio
        6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
    6.11 Verdant Life Sciences
        6.11.1 Verdant Life Sciences Corporation Information
        6.11.2 Verdant Life Sciences Irbesartan Description and Business Overview
        6.11.3 Verdant Life Sciences Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Verdant Life Sciences Product Portfolio
        6.11.5 Verdant Life Sciences Recent Developments/Updates
    6.12 Angita Pharma
        6.12.1 Angita Pharma Corporation Information
        6.12.2 Angita Pharma Irbesartan Description and Business Overview
        6.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Angita Pharma Product Portfolio
        6.12.5 Angita Pharma Recent Developments/Updates
    6.13 Auro Pharma
        6.13.1 Auro Pharma Corporation Information
        6.13.2 Auro Pharma Irbesartan Description and Business Overview
        6.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Auro Pharma Product Portfolio
        6.13.5 Auro Pharma Recent Developments/Updates
    6.14 Avanstra
        6.14.1 Avanstra Corporation Information
        6.14.2 Avanstra Irbesartan Description and Business Overview
        6.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Avanstra Product Portfolio
        6.14.5 Avanstra Recent Developments/Updates
    6.15 Zhuhai Rundu Pharma
        6.15.1 Zhuhai Rundu Pharma Corporation Information
        6.15.2 Zhuhai Rundu Pharma Irbesartan Description and Business Overview
        6.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Zhuhai Rundu Pharma Product Portfolio
        6.15.5 Zhuhai Rundu Pharma Recent Developments/Updates
    6.16 Xiansheng Pharmaceutical
        6.16.1 Xiansheng Pharmaceutical Corporation Information
        6.16.2 Xiansheng Pharmaceutical Irbesartan Description and Business Overview
        6.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Xiansheng Pharmaceutical Product Portfolio
        6.16.5 Xiansheng Pharmaceutical Recent Developments/Updates
    6.17 CTTQ
        6.17.1 CTTQ Corporation Information
        6.17.2 CTTQ Irbesartan Description and Business Overview
        6.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 CTTQ Product Portfolio
        6.17.5 CTTQ Recent Developments/Updates
    6.18 Tianjin Huairen Pharmaceutical
        6.18.1 Tianjin Huairen Pharmaceutical Corporation Information
        6.18.2 Tianjin Huairen Pharmaceutical Irbesartan Description and Business Overview
        6.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 Tianjin Huairen Pharmaceutical Product Portfolio
        6.18.5 Tianjin Huairen Pharmaceutical Recent Developments/Updates
    6.19 Jiangsu Wangao Pharmaceutical
        6.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
        6.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Description and Business Overview
        6.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Jiangsu Wangao Pharmaceutical Product Portfolio
        6.19.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
    6.20 Zhejiang Huahai Pharmaceutical
        6.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
        6.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Description and Business Overview
        6.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Zhejiang Huahai Pharmaceutical Product Portfolio
        6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
    6.21 Zhejiang Ainuo Pharmaceutical
        6.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
        6.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Description and Business Overview
        6.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Zhejiang Ainuo Pharmaceutical Product Portfolio
        6.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
    6.22 Yuanhe Pharmaceutical
        6.22.1 Yuanhe Pharmaceutical Corporation Information
        6.22.2 Yuanhe Pharmaceutical Irbesartan Description and Business Overview
        6.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Yuanhe Pharmaceutical Product Portfolio
        6.22.5 Yuanhe Pharmaceutical Recent Developments/Updates

7 Irbesartan Manufacturing Cost Analysis
    7.1 Irbesartan Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Irbesartan
    7.4 Irbesartan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Irbesartan Distributors List
    8.3 Irbesartan Customers

9 Irbesartan Market Dynamics
    9.1 Irbesartan Industry Trends
    9.2 Irbesartan Growth Drivers
    9.3 Irbesartan Market Challenges
    9.4 Irbesartan Market Restraints

10 Global Market Forecast
    10.1 Irbesartan Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Irbesartan by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Irbesartan by Type (2022-2027)
    10.2 Irbesartan Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Irbesartan by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Irbesartan by Application (2022-2027)
    10.3 Irbesartan Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Irbesartan by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Irbesartan by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Irbesartan Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Irbesartan Sales (KG) Comparison by Application (2021-2027) Table 3. Global Irbesartan Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Irbesartan Covered in This Study Table 5. Global Irbesartan Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Irbesartan Sales Share by Manufacturers (2016-2021) Table 7. Global Irbesartan Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Irbesartan Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Irbesartan Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Irbesartan Manufacturing Sites and Area Served Table 11. Manufacturers Irbesartan Product Type Table 12. Global Irbesartan Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Irbesartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irbesartan as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Irbesartan Sales by Region (2016-2021) & (KG) Table 16. Global Irbesartan Sales Market Share by Region (2016-2021) Table 17. Global Irbesartan Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Irbesartan Sales by Country (2016-2021) & (KG) Table 19. North America Irbesartan Sales Market Share by Country (2016-2021) Table 20. North America Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Irbesartan Revenue Market Share by Country (2016-2021) Table 22. Europe Irbesartan Sales by Country (2016-2021) & (KG) Table 23. Europe Irbesartan Sales Market Share by Country (2016-2021) Table 24. Europe Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Irbesartan Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Irbesartan Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Irbesartan Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Irbesartan Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Irbesartan Revenue Market Share by Region (2016-2021) Table 30. Latin America Irbesartan Sales by Country (2016-2021) & (KG) Table 31. Latin America Irbesartan Sales Market Share by Country (2016-2021) Table 32. Latin America Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Irbesartan Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Irbesartan Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Irbesartan Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Irbesartan Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Irbesartan Revenue Market Share by Country (2016-2021) Table 38. Global Irbesartan Sales (KG) by Type (2016-2021) Table 39. Global Irbesartan Sales Market Share by Type (2016-2021) Table 40. Global Irbesartan Revenue (Million US$) by Type (2016-2021) Table 41. Global Irbesartan Revenue Share by Type (2016-2021) Table 42. Global Irbesartan Price (US$/G) by Type (2016-2021) Table 43. Global Irbesartan Sales (KG) by Application (2016-2021) Table 44. Global Irbesartan Sales Market Share by Application (2016-2021) Table 45. Global Irbesartan Revenue (Million US$) by Application (2016-2021) Table 46. Global Irbesartan Revenue Share by Application (2016-2021) Table 47. Global Irbesartan Price (US$/G) by Application (2016-2021) Table 48. Teva Corporation Information Table 49. Teva Description and Business Overview Table 50. Teva Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Teva Irbesartan Product Table 52. Teva Recent Developments/Updates Table 53. Sanofi Corporation Information Table 54. Sanofi Description and Business Overview Table 55. Sanofi Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. Sanofi Irbesartan Product Table 57. Sanofi Recent Developments/Updates Table 58. BMS Corporation Information Table 59. BMS Description and Business Overview Table 60. BMS Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. BMS Irbesartan Product Table 62. BMS Recent Developments/Updates Table 63. Sumitomo Dainippon Pharma Corporation Information Table 64. Sumitomo Dainippon Pharma Description and Business Overview Table 65. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. Sumitomo Dainippon Pharma Irbesartan Product Table 67. Sumitomo Dainippon Pharma Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. Novartis Irbesartan Product Table 72. Novartis Recent Developments/Updates Table 73. Shionogi Corporation Information Table 74. Shionogi Description and Business Overview Table 75. Shionogi Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. Shionogi Irbesartan Product Table 77. Shionogi Recent Developments/Updates Table 78. Hanall Corporation Information Table 79. Hanall Description and Business Overview Table 80. Hanall Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Hanall Irbesartan Product Table 82. Hanall Recent Developments/Updates Table 83. Taj Pharmaceuticals Corporation Information Table 84. Taj Pharmaceuticals Description and Business Overview Table 85. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Taj Pharmaceuticals Irbesartan Product Table 87. Taj Pharmaceuticals Recent Developments/Updates Table 88. Apotex Corporation Information Table 89. Apotex Description and Business Overview Table 90. Apotex Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. Apotex Irbesartan Product Table 92. Apotex Recent Developments/Updates Table 93. Jiangsu Hengrui Medicine Corporation Information Table 94. Jiangsu Hengrui Medicine Description and Business Overview Table 95. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Jiangsu Hengrui Medicine Irbesartan Product Table 97. Jiangsu Hengrui Medicine Recent Developments/Updates Table 98. Verdant Life Sciences Corporation Information Table 99. Verdant Life Sciences Description and Business Overview Table 100. Verdant Life Sciences Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. Verdant Life Sciences Irbesartan Product Table 102. Verdant Life Sciences Recent Developments/Updates Table 103. Angita Pharma Corporation Information Table 104. Angita Pharma Description and Business Overview Table 105. Angita Pharma Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. Angita Pharma Irbesartan Product Table 107. Angita Pharma Recent Developments/Updates Table 108. Auro Pharma Corporation Information Table 109. Auro Pharma Description and Business Overview Table 110. Auro Pharma Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Auro Pharma Irbesartan Product Table 112. Auro Pharma Recent Developments/Updates Table 113. Avanstra Corporation Information Table 114. Avanstra Description and Business Overview Table 115. Avanstra Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. Avanstra Irbesartan Product Table 117. Avanstra Recent Developments/Updates Table 118. Zhuhai Rundu Pharma Corporation Information Table 119. Zhuhai Rundu Pharma Description and Business Overview Table 120. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Zhuhai Rundu Pharma Irbesartan Product Table 122. Zhuhai Rundu Pharma Recent Developments/Updates Table 123. Xiansheng Pharmaceutical Corporation Information Table 124. Xiansheng Pharmaceutical Description and Business Overview Table 125. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. Xiansheng Pharmaceutical Irbesartan Product Table 127. Xiansheng Pharmaceutical Recent Developments/Updates Table 128. CTTQ Corporation Information Table 129. CTTQ Description and Business Overview Table 130. CTTQ Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. CTTQ Irbesartan Product Table 132. CTTQ Recent Developments/Updates Table 133. Tianjin Huairen Pharmaceutical Corporation Information Table 134. Tianjin Huairen Pharmaceutical Description and Business Overview Table 135. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. Tianjin Huairen Pharmaceutical Irbesartan Product Table 137. Tianjin Huairen Pharmaceutical Recent Developments/Updates Table 138. Jiangsu Wangao Pharmaceutical Corporation Information Table 139. Jiangsu Wangao Pharmaceutical Description and Business Overview Table 140. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. Jiangsu Wangao Pharmaceutical Irbesartan Product Table 142. Jiangsu Wangao Pharmaceutical Recent Developments/Updates Table 143. Zhejiang Huahai Pharmaceutical Corporation Information Table 144. Zhejiang Huahai Pharmaceutical Description and Business Overview Table 145. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Zhejiang Huahai Pharmaceutical Irbesartan Product Table 147. Zhejiang Huahai Pharmaceutical Recent Developments/Updates Table 148. Zhejiang Ainuo Pharmaceutical Corporation Information Table 149. Zhejiang Ainuo Pharmaceutical Description and Business Overview Table 150. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Zhejiang Ainuo Pharmaceutical Irbesartan Product Table 152. Zhejiang Ainuo Pharmaceutical Recent Developments/Updates Table 153. Yuanhe Pharmaceutical Corporation Information Table 154. Yuanhe Pharmaceutical Description and Business Overview Table 155. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Yuanhe Pharmaceutical Irbesartan Product Table 157. Yuanhe Pharmaceutical Recent Developments/Updates Table 158. Production Base and Market Concentration Rate of Raw Material Table 159. Key Suppliers of Raw Materials Table 160. Irbesartan Distributors List Table 161. Irbesartan Customers List Table 162. Irbesartan Market Trends Table 163. Irbesartan Growth Drivers Table 164. Irbesartan Market Restraints Table 165. Global Irbesartan Sales Forecast by Type (2022-2027) & (KG) Table 166. Global Irbesartan Sales Market Share Forecast by Type (2022-2027) Table 167. Global Irbesartan Revenue Forecast by Type (2022-2027) & (US$ Million) Table 168. Global Irbesartan Revenue Market Share Forecast by Type (2022-2027) Table 169. Global Irbesartan Sales Forecast by Application (2022-2027) & (KG) Table 170. Global Irbesartan Sales Market Share Forecast by Application (2022-2027) Table 171. Global Irbesartan Revenue Forecast by Application (2022-2027) & (US$ Million) Table 172. Global Irbesartan Revenue Market Share Forecast by Application (2022-2027) Table 173. Global Irbesartan Sales Forecast by Region (2022-2027) & (KG) Table 174. Global Irbesartan Sales Market Share Forecast by Region (2022-2027) Table 175. Global Irbesartan Revenue Forecast by Region (2022-2027) & (US$ Million) Table 176. Global Irbesartan Revenue Market Share Forecast by Region (2022-2027) Table 177. Research Programs/Design for This Report Table 178. Key Data Information from Secondary Sources Table 179. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Irbesartan Figure 2. Global Irbesartan Market Share by Type in 2020 & 2027 Figure 3. Combination Drugs Product Picture Figure 4. Prescribed Drugs Product Picture Figure 5. Global Irbesartan Market Share by Application in 2020 & 2027 Figure 6. Hyperlipidemia Figure 7. High Blood Pressure Figure 8. Heart Failure Figure 9. Kidney Disease Figure 10. Fibrous Fibrillation Figure 11. Other Figure 12. Global Irbesartan Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Irbesartan Market Size 2016-2027 (US$ Million) Figure 14. Global Irbesartan Sales 2016-2027 (KG) Figure 15. Global Irbesartan Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Irbesartan Sales Share by Manufacturers in 2020 Figure 17. Global Irbesartan Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Irbesartan Players: Market Share by Revenue in 2020 Figure 19. Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Irbesartan Sales Market Share by Region (2016-2021) Figure 21. Global Irbesartan Sales Market Share by Region in 2020 Figure 22. Global Irbesartan Revenue Market Share by Region (2016-2021) Figure 23. Global Irbesartan Revenue Market Share by Region in 2020 Figure 24. U.S. Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. UAE Irbesartan Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Irbesartan by Type (2016-2021) Figure 49. Sales Market Share of Irbesartan by Application (2016-2021) Figure 50. Sales Market Share of Irbesartan by Application in 2020 Figure 51. Revenue Share of Irbesartan by Application (2016-2021) Figure 52. Revenue Share of Irbesartan by Application in 2020 Figure 53. Manufacturing Cost Structure of Irbesartan Figure 54. Manufacturing Process Analysis of Irbesartan Figure 55. Irbesartan Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us